| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |